Microarray analysis of a reversible model and an irreversible model of anti-Thy-1 nephritis  by Tsuji, M. et al.
Microarray analysis of a reversible model and an
irreversible model of anti-Thy-1 nephritis
M Tsuji1, T Monkawa1, J Yoshino1, M Asai1, S Fukuda1, H Kawachi2, F Shimizu2, M Hayashi1 and T Saruta1
1Department of Internal Medicine, Keio University School of Medicine, Tokyo, Japan and 2Department of Cell Biology, Institute of
Nephrology, Niigata University Graduate School of Medical and Dental Sciences, Niigata, Japan
A single intravenous injection of anti-Thy-1 monoclonal
antibody (mAb) 1-22-3 is known to cause reversible
mesangial proliferative glomerulonephritis. However, mAb
1-22-3 injection followed by unilateral nephrectomy leads to
progressive glomerulosclerosis and tubulointerstitial change
with an irreversible course. To identify genes that play an
important role in the irreversible progression of renal injury,
we used microarray technology to identify differences in
gene expression between these models. Rats were
intravenously injected with mAb 1-22-3 1 week after
unilateral nephrectomy (irreversible model) or a sham
operation (reversible model), and rats were killed on days 4,
7, 14, 42, and 56 after the injection. complementary DNA
probes prepared from kidney messenger RNAs were
hybridized with oligonucleotide microarrays containing 4854
rat genes. The microarray identified 189 differentially
expressed genes, having at least a two-fold difference in
expression level between the two models, and they were
classified into five clusters. One of the clusters consisted of
genes whose expression was markedly upregulated in the
irreversible model. This cluster included the genes encoding
osteopontin, kidney injury molecule-1, and thymosin b10.
Increased expression of thymosin b10 was localized mainly in
macrophages in the fibrotic interstitium, and upregulation of
thymosin b10 expression was also observed in a unilateral
ureteral obstruction model. The microarray analysis yielded
information on the molecular mechanisms responsible for
the difference in disease progression between the reversible
and irreversible model of anti-Thy-1 nephritis. Thymosin b10
may play an important role in the progression of kidney
disease.
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The common pathological feature of the progressive
renal diseases is glomerulosclerosis and tubulointer-
stitial fibrosis, but the pathogenic mechanisms underlying
the progressive renal lesions are poorly understood.
Our limited understanding may be attributable to a lack
of appropriate animal models, and a model of progressive
sclerotic lesions induced by anti-Thy-1 monoclonal anti-
body (mAb) 1-22-3 in rats has been developed to study
the mechanisms of renal disease progression. Anti-Thy-1
nephritis is most commonly used as a model of
mesangial proliferative glomerulonephritis; it is self-limiting,
and the glomerular architecture returns to normal within 6–8
weeks.1 A single injection of mAb 1-22-3 to unilaterally
nephrectomized rats, on the other hand, causes irreversible
glomerulosclerosis and tubular interstitial change (irreversi-
ble model), whereas the disease course of the sham-operated
rats injected with mAb 1-22-3 is reversible (reversible
model).2–4 In the irreversible anti-Thy-1 nephritis model,
urinary protein persists and typical sclerotic renal lesions are
observed after a month. Several mechanisms have been
proposed to explain the irreversible models, but the actual
mechanism of the irreversible model has never been fully
elucidated.
In recent years, great advances have been made in
techniques to analyze and compare differentially expressed
genes, and complementary DNA (cDNA)/oligonucleotide
microarray technology is a particularly useful development
because it provides parallel and quantitative expression
profiles of thousands of genes that can identify genes in a
biologic pathway, characterize the function of novel genes,
and identify drug targets.
The purpose of this study was to utilize oligonucleo-
tide microarrays to define differences in global changes
in renal gene expression between irreversible and reversible
models of anti-Thy-1 nephritis, and, specifically, to identify
genes that play an important role in disease progression.
In the present study, we identified a gene cluster that
is upregulated in the irreversible model. Increased expre-
ssion of thymosin b10 in the cluster was observed mainly
in the macrophages in the fibrotic interstitium of the
kidney. These findings suggest that osteopontin and
thymosin b10 may be involved in the progression of renal
disease.
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RESULTS
Reversible and irreversible models of anti-Thy-1 nephritis
To produce the reversible anti-Thy-1 nephritis model, rats
were sham-operated, and 1 week later injected with mAb
1-22-3. For the irreversible anti-Thy-1 nephritis model, rats
were unilaterally nephrectomized, and 1 week later injected
with mAb 1-22-3. The time course of urinary protein
excretion is shown in Figure 1. Urinary protein excretion
peaked at day 7 in both models. The proteinuria in the
irreversible model persisted until 2 months after the mAb
injection, whereas in the reversible model urinary protein
excretion became normal by day 21. No significant urinary
protein excretion was seen in the control group of rats
unilaterally nephrectomized and not injected with mAb 1-22-3.
Histological analysis of the kidneys on day 4 showed
diffuse mesangiolytic changes in both the reversible and
irreversible models. On day 14, there were significant
increases in glomerular cell number and marked expansion
of the mesangial area in both models. By day 56, the
mesangial cell proliferation had markedly decreased. Glo-
merular crescentic lesions and tubulointerstitial changes,
including tubular hyaline casts, tubule dilation, and leukocyte
infiltration, were more common in the irreversible model.
These histological findings are consistent with previous
observations.5
Gene expression profiles
To identify genes that play an important role in the
irreversible progression of renal diseases, we investigated
difference in gene expression between the reversible model
and irreversible model of anti-Thy-1 nephritis using an
oligonucleotide microarray technology. Messenger RNA
(mRNA) was prepared from the kidneys of both models at
each time point and labeled with Cy-dye during reverse
transcription. Labeled cDNAs were hybridized with the
microarray slide containing 4854 rat genes, and the
expression level of 189 genes differed by more than two-
fold between the reversible model and irreversible model at
one or more time points. The numbers of differentially
regulated genes are shown in Table 1. The majority of the
differentially expressed genes were genes that were upregu-
lated at day 4 in the reversible model (167 out of 189 genes,
88.4%). To clarify the function of the 189 differentially
expressed genes, they were subjected to clustering analysis
based on expression patterns and classified into five clusters
(cluster A–E), as shown in Figure 2. The genes identified are
tabulated in Table 2.
Cluster A consisted of 13 genes that were differentially
expressed in the irreversible model, especially at days 4, 42,
and 56. As the microarray results represent the ratio between
the mRNA expression in the two models, and do not
represent the actual levels of mRNA expression, the mRNA
expression levels were examined by semiquantitative reverse
transcription-polymerase chain reaction (RT-PCR) for se-
lected genes in cluster A (Figure 3). Semiquantitative PCR
analysis revealed that the expression levels of the genes
examined peaked at days 7–14, and that the upregulation was
more pronounced in the irreversible model than in the
reversible model. Thus, the gene expression pattern in this
cluster was characterized by upregulation in the irreversible
model. The genes whose expression in the kidney differed
between the reversible model and the irreversible model of
anti-Thy-1 nephritis at days 42 and 56 are shown in Tables 3
and 4, respectively. Most of the cluster A genes were seen in
the list of the gene differentially expressed in the progressive
phase of the disease.
Cluster C was the largest cluster and contained 170 genes
that were differentially expressed in the reversible model at
day 4 but for which no clear difference in expression levels
was observed between the two models subsequently.
Semiquantitative RT-PCR for Aldo-keto reductase family 1
member B7, uridine diphosphate glycosyltransferase 1 family
polypeptide A6, and glutathione peroxidase 3 revealed the
most striking change in mRNA expression to be a decrease in
the irreversible model at day 4 (Figure 3). The functions of
the genes in cluster C are in metabolism (83 genes), transport
(25 genes), signal transduction (12 genes), developmental
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Figure 1 | Time course of urinary protein excretion after mAb
1-22-3 injection. The amount of protein in 24 h urine was measured
before the mAb 1-22-3 injection and 4, 7, 14, 21, 24, 42, 49, and 56
days after the mAb 1-22-3 injection. &, irreversible model,
unilaterally nephrectomized and injected with mAb 1-22-3; K,
reversible model, sham-operated and injected with mAb 1-22-3; W,
control rats, unilaterally nephrectomized and not injected with mAb
1-22-3. Proteinuria persisted for 2 months in the irreversible model,
whereas urinary protein excretion in the reversible model became
normal by day 21 after the mAb 1-22-3 injection. No proteinuria was
detected in control rats. *Po0.05 vs control rat. #Po0.05 vs the
reversible model.
Table 1 | Numbers of differentially regulated genes revealed
by the microarray analysis
Day after injection
4 7 14 42 56
Irreversible4reversible model 13 1 1 8 3
Irreversibleoreversible model 167 10 7 2 1
The numbers of genes in the kidney at each time point that were differentially
expressed by at least two-fold in the irreversible model (upper row) and in the
reversible model (lower row) of anti-Thy-1 nephritis are shown.
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processes (11 genes), unknown (10 genes), and other (29
genes).
To exclude the possibility that nephrectomy itself affects
gene expression, gene expression in unilaterally nephrecto-
mized rats without mAb injection and control rats was
compared by microarray analysis; however, no genes were
differentially expressed (data not shown).
KIM-1, osteopontin, and thymosin b10
To investigate genes involved in progression of the disease, we
focused on analysis of the genes in cluster A, and selected
kidney injury molecule-1 (KIM-1), osteopontin, and thymo-
sin b10 for further investigation. Real-time PCR analysis
showed that the expression level of all three genes was low in
the normal kidney but increased and peaked at day 14, and
that their upregulation was more pronounced in the
irreversible model than in the reversible model (Figure 4).
Overexpression of all the three genes in the irreversible model
persisted until days 42 and 56, when the expression in the
reversible model decreased.
Cluster A genes in the UUO model
The next step was to determine whether the genes
upregulated in the irreversible model were upregulated in
another kidney disease model, and we selected the unilateral
ureteral obstruction (UUO) model, a well-characterized
model of tubulointerstitial fibrosis. Establishment of ob-
structive nephritis was confirmed by histology and collagen I
expression (data not shown). Real-time PCR analysis showed
that KIM-1 mRNA was strongly upregulated on the
obstructed side in comparison with the control kidney
(Figure 5). The increase in expression on the obstructed side
peaked at day 4, and gradually decreased thereafter. Osteo-
pontin and thymosin b10 were also upregulated on the
obstructed side, but the upregulation persisted until day 21.
These findings suggest that KIM-1 expression is more closely
associated with the initial kidney insult and that osteopontin
and thymosin b10 expression is more related to the progression
of kidney disease.
Immunolocalization of thymosin b10
Thymosin b10 expression in renal sections from control rats
was low, and very few cells were positive in the tubulointer-
stitium (data not shown). Thymosin b10 expression was
increased in both anti-Thy-1 nephritis models, and its
maximal level occurred in the irreversible model at days 7
and 14. Thymosin b10 expression was mainly found in the
interstitium (Figure 6a). The immunostaining of Thymosin
b10 in the reversible model was weaker than that in the
irreversible model at day 14 (Figure 6b). Thymosin b10
expression was also observed in the dilated fibrotic
interstitium of the kidney on the obstructed side in the
UUO model (Figure 6c). Double immunostaining with anti-
thymosin b10 antibody and the macrophage marker ED-1
revealed that most of the cells that were positive for thymosin
b10 were macrophages (Figure 6d–f).
DISCUSSION
This study used microarray technology to investigate global
gene expression in a model of progressive renal disease in
order to elucidate the molecular mechanism of progression of
kidney diseases. We used the irreversible anti-Thy-1 nephritis
model as the model of progressive renal disease and produced
it by intravenously injecting unilaterally nephrectomized rats
with mAb 1-22-3. The irreversible anti-Thy-1 nephritis
model offers several advantages over other models of chronic
renal disease. First, it is easy to produce and yields more
reproducible results than the 5/6-nephrectomized rat model,
another model of progressive renal disease. Second, it is easy
to compare gene expression with the corresponding reversible
model because they have the same genetic background.
Third, it pursues a progressive course following immune-
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Figure 2 | Cluster analysis of differentially expressed genes
identified by microarray analysis of reversible and irreversible
models of anti-Thy-1 nephritis. (a) Hierarchical clustering of genes
whose expression levels differed between the reversible and
irreversible models. The temporal expression profiles of 189 genes
whose intensity differed two-fold or more between the two models
at least at one time point were subjected to hierarchical clustering
analysis with CLUSTER software and visualized in a clustergram with
TREEVIEW software. Days after antibody injection are represented by
columns, and the genes are listed in rows. Green indicates differential
expression in the reversible model and red indicates differential
expression in the irreversible model at distinct time points. The
degree of color saturation reflects the magnitude of the ratio. Black
indicates genes whose expression did not differ between the two
models. (b) Temporal patterns of gene expression within each cluster.
The x-axis shows the time course and the y-axis shows the average
value of the log 2 ratios of expression levels in the irreversible model/
reversible model.
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initiated kidney disease, and thus is regarded as the model
that most closely mimics human chronic nephritis.
The microarray analysis of the irreversible model and
reversible model identified 189 differentially expressed genes.
Interestingly, the differential expression of the majority of
these genes was found on day 4, and the mRNA expression of
very few genes differed later. Thus, early alterations in gene
expression may determine the irreversibility of the disease.
This possibility was investigated by Ostendorf et al.6 They
found that early treatment prevented progression of the
disease in irreversible anti-Thy-1 nephritis. When oligo-
nucleotide aptamer antagonist against PDGF-B, which
specifically inhibits PDGF activity, is administered on days
3 and 7 of the irreversible anti-Thy-1 nephritis model, the
subsequent sclerotic lesions are less severe.
Clustering analysis of the differentially expressed genes
was performed based on their temporal expression patterns
to clarify the function, and the differentially expressed genes
were classified into five clusters. The most interesting cluster
was cluster A. The genes in cluster A were upregulated in the
diseased kidney and were more strongly expressed in the
irreversible model than in the reversible model. Cluster A
contained the genes encoding collagen I a1 and laminin g1,
which are profibrotic genes associated with the deposition of
extracellular matrix. It also contained the genes encoding
KIM-1, osteopontin, and thymosin b10.
Table 2 | Genes whose expression in the kidney differed between the reversible model and the irreversible model of anti-Thy-1
nephritis
Log ratio of differential expression
Gene accession Name Day 4 Day 7 Day 14 Day 42 Day 56
Cluster A
AF035963 Kidney injury molecule 1 2.5570.29 0.0970.21 0.570.49 1.3470.21 0.9570.36
U56822 Killer cell lectin-like receptor subfamily A, member 22 2.4170.10 0.1070.16 0.5870.39 1.2570.26 0.7770.36
U87224 Contactin associated protein 1 2.1270.19 0.0470.17 0.4470.23 0.9570.31 0.5470.04
M12199 Collagen, type I, alpha 1 1.6870.28 0.1570.59 0.2370.81 0.4970.24 0.7370.28
AF091577 Olfactory receptor gene Olr1370 1.6770.27 0.3170.10 0.7970.26 2.0270.18 1.0570.19
AF198087 Adrenal secretory serine protease precursor 1.6270.12 0.0270.61 0.8770.48 1.9370.04 0.9770.22
NM_012868 Natriuretic peptide receptor 3 1.6270.31 0.3570.34 0.5670.53 1.8070.13 0.9570.27
NM_012881 Osteopontin 1.5470.63 0.1370.37 1.0170.58 1.9870.23 1.0370.07
X89698 Olfactory receptor gene Olr737 1.5270.59 0.3770.23 0.4970.33 1.4170.59 0.8770.15
AF016178 Putative pheromone receptor (Go-VN1) 1.4770.30 0.3670.31 0.5570.43 1.6170.05 0.9270.21
X94551 Laminin, gamma 1 1.4670.13 0.0970.19 0.4270.27 0.6770.37 0.4470.17
AF218574 Meiotic recombination 11 homolog A (S. cerevisiae) 1.4370.74 1.2370.74 0.2070.43 0.6870.45 0.4870.33
M58404 Thymosin, beta 10 1.1670.50 0.0270.20 0.6570.18 0.8270.19 0.7670.22
Cluster B
NM_017260 Arachidonate 5-lipoxygenase activating protein 0.5670.74 0.2271.00 0.1770.29 1.0170.17 0.2070.57
M33936 Cytochrome P450, family 4, subfamily a, polypeptide 14 0.5470.71 0.0770.99 0.2470.26 1.2170.11 0.3470.45
Cluster C
AF182168 Aldo-keto reductase family 1, member B7 2.3870.98 0.1070.29 0.4870.36 0.1570.47 0.6670.64
S70366 UDP glycosyltransferase 1 family, polypeptide A6 2.3370.48 1.0870.31 0.4470.27 0.0170.34 0.8070.83
D00680 Glutathione peroxidase 3 2.3270.13 0.1470.44 0.6370.05 0.4870.14 0.7570.04
NM_017217 Solute carrier family 7, member 3 1.9670.39 1.3170.22 0.2670.26 0.8470.22 0.4670.56
M83144 Beta-galactoside-alpha 2,6-sialyltransferase 1.9670.42 0.3670.27 1.1270.58 0.1670.32 0.5670.83
NM_013184 Neurotrophin 5 1.9570.25 0.8970.16 0.3970.27 0.0770.34 0.7370.82
S79716 Class VI alcohol dehydrogenase 1.9370.35 0.8470.27 0.3470.13 0.0170.33 0.7070.92
NM_012674 Serine protease inhibitor, Kazal type 1 1.9271.36 0.5870.12 0.2270.15 0.1870.3 0.0770.05
NM_019192 Selenoprotein P, plasma, 1 1.8670.14 0.4870.13 0.1270.13 0.2370.23 0.1670.48
M11842 Ornithine aminotransferase 1.8470.57 1.0470.23 0.2470.20 0.7370.33 0.2770.64
AF205717 Transmembrane 4 superfamily member 4 1.6870.92 0.6670.07 0.3270.22 0.0270.37 0.6870.37
NM_019286 Alcohol dehydrogenase 1 1.6770.42 0.4770.21 0.1670.19 0.2170.18 0.2270.29
X05341 Acetyl-coenzyme A acyltransferase 2 1.6570.35 0.2470.25 0.0770.17 0.1270.16 0.1170.23
U25808 Kidney androgen regulated protein 1.3970.07 1.5170.61 2.0371.00 0.9870.17 0.8070.13
Cluster D
M32510 Hemoglobin alpha, adult chain 1 0.6470.43 0.3570.47 1.2570.40 0.8870.28 0.4470.98
AF005099 Neuronal pentraxin receptor 0.5670.48 0.3870.46 1.1970.49 0.1571.10 0.4170.87
M32509 Hemoglobin beta chain complex 0.8370.17 0.5770.24 1.1170.27 0.7570.11 0.4170.80
Cluster E
U06274 UDP glycosyltransferase 2 family, polypeptide B4 0.9971.97 0.5971.54 1.3372.05 0.6271.17 1.1270.46
The values shown are means of the log 2 ratios of (irreversible model/reversible model) samples7s.d. Thus, a positive value indicates differential expression in the irreversible
model, and a negative value indicates differential expression in the reversible model.
Cluster C contains 170 genes, but this table shows only the 14 genes whose expression level was three-fold or more different in the reversible model than in the irreversible
model at one or more time points.
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KIM-1 is a type 1 membrane protein with extracellular
immunoglobulin and mucin domains. KIM-1 is expressed at
very low levels in the normal kidney, but its expression
increases dramatically in the proximal tubule epithelial cells
of the postischemic kidney.7 We found that KIM-1 is
upregulated in the anti-Thy-1 nephritis models, and more
strongly expressed in the irreversible model. The increase in
expression in the UUO model peaked at day 4, and it
gradually decreased thereafter, suggesting that KIM-1 is
associated with the initial insult rather than with progression
of the disease. This is supported by the observation that
KIM-1 is strongly expressed in acute renal failure, but weakly
expressed in chronic renal disease.8
Osteopontin is a potent chemotactic molecule for
macrophages, and upregulated expression by proximal
tubular epithelial cells in association with monocyte/macro-
phage infiltrates has been described in a number of rodent
models of renal injury and in human renal diseases.9–11
Thymosin b10 is a small acidic peptide that binds to G-actin
and inhibits actin polymerization. Overexpression of thymo-
sin b10 has been detected in many neoplastic tissues, and
thymosin b10 is known to inhibit angiogenesis and accelerate
apoptosis.12–14 Although expression of thymosin b10 has
been reported to be upregulated in the developing
kidney,15,16 there have been no reports on involvement in
kidney disease. In this study, we for the first time found that
thymosin b10 is upregulated in the anti-Thy-1 nephritis
models and the UUO model. The thymosin b10 was localized
in the fibrotic interstitium. Double immunostaining with the
macrophage marker ED-1 revealed that most of the cells that
were positive for thymosin b10 were macrophages. Although
there have been a few studies on thymosin b10 expression in
monocytes/macrophages,17–19 little is known about the
function of thymosin b10 in macrophages.
Based on the overexpression of osteopontin and thymosin
b10 in the irreversible Thy-1 model and the UUO model, we
speculate that a possible mechanism for the common
pathway of the progression of renal diseases involves
macrophage infiltration and activation in the fibrotic
interstitium. Although interstitial fibrosis of the irreversible
model of anti-Thy-1 nephritis has not been investigated
extensively, we observed significant infiltration of macro-
phages in the tubulointerstitium of the irreversible Thy-1
model (Figure 6e). In the UUO model, a large number of
blood-derived macrophages accumulate in the tubulointer-
stitial space.20 The infiltrating macrophages have been shown
to play a pivotal role in the development of interstitial
fibrosis in the UUO model. Lack of chemokines receptor
CCR1 reduced recruitment of leukocytes and macrophages
and suppressed renal fibrosis in the UUO model.21 Interstitial
macrophages are a common feature of most forms of
progressive renal damage, including those not generally
considered to be inflammatory, such as diabetic nephro-
pathy.22 At this time, we do not know the mechanism
responsible for the greater upregulation of osteopontin and
thymosin b10 in unilaterally nephrectomized rats.
Cluster C is the largest cluster, and is characterized by
differential expression in the reversible model at day 4.
Semiquantitative RT-PCR analysis of selected genes in cluster
C revealed that the change in the ratio of expression levels at
day 4 reflects decreased expression in the irreversible model.
The majority of the genes, including the genes encoding
transporters (aquaporin 1 and 4, anion exchange protein 1,
and bumetanide-sensitive Na–K–2Cl cotransporter), kidney-
specific androgen-regulated protein, megalin, Tamm-Horsfall
protein, and carbonic anhydrase 2, are constitutively
expressed in tubular cells, suggesting that anti-Thy-1 anti-
body induces early severer damage not only in glomerular
cells but also in the tubular cells in the remaining kidney of
nephrectomized rats than unnephrectomized rats. The
damage may lead to decreased expression of genes that are
constitutively expressed in tubular cells.
Unilateral nephrectomy itself may affect the remaining
kidney. When the same microarray slide was used to compare
gene expression in unilaterally nephrectomized rats not
injected with mAb and control rats, no genes were found to
be differentially expressed. Although we cannot detect
differential expression, micropuncture studies have revealed
that glomerular capillary hydraulic pressure and the glomer-
ular transcapillary pressure difference increase significantly
after nephrectomy.23 A rise in glomerular capillary hydraulic
pressure increases capillary wall tension, and the resulting
stretching of the capillary wall stimulates endothelial expres-
sion of cell adhesion molecules,24 and induces the production
of vasoactive substances and cytokines, such as angiotensino-
gen and transforming growth factor-b, by injured or activated
endothelium, which may exacerbate glomerular inflammation
and lead to progressive glomerulosclerosis.
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Figure 3 | Semiquantitative RT-PCR for the selected genes in the
kidney in the reversible and irreversible models of anti-Thy-1
nephritis. mRNA was prepared from kidneys of the control rats (C),
irreversible model rats (IR), and reversible model rats (R) at the times
indicated and subjected to semiquantitative RT-PCR. Kidney injury
molecule-1 (KIM-1), osteopontin, collagen I a1, laminin g1, and
thymosin b10 belong to cluster A. Aldo-keto reductase family 1,
member B7 (Akr1b7), uridine diphosphate glycosyltransferase 1
family, polypeptide A6 (Ugt1a6), and glutathione peroxidase 3 (Gpx3)
belong to cluster C.
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A possible criticism of the effect of nephrectomy is
the difference in the amount of kidney binding mAb 1-22-3
in the nephrectomized and intact rats. However, our
previous quantitative study with various doses of mAb
1-22-3 showed no significant difference in infiltrating cells
or severity of mesangial alterations between rats injected with
0.5 and 10 mg.3,25 Even when the rats were injected with a
single dose of mAb 1-22-3 and subjected to unilateral
nephrectomy, they exhibited a progressive course.26 These
observations indicate that the difference in the amount of
kidney binding antibody between the sham-operated
group and unilaterally nephrectomized group had little effect
with regard to the different outcomes of the disease. We
therefore speculate that nephrectomy may cause ‘cell
priming’ that induces no more than very subtle, barely
detectable changes in the cells, and that injection of mAb
1-22-3 into the primed cells injures them beyond the
threshold of no return.
In conclusion, the microarray analysis in the irreversible
model and reversible model of anti-Thy-1 nephritis identified
189 differentially expressed genes, and they were classified
into five clusters. Genes that are constitutively expressed in
tubular cells were downregulated in the irreversible model at
day 4, suggesting that mAb 1-22-3 causes more severe injury
to tubular cells as well as glomerular cells in nephrectomized
rats than in unnephrectomized rats. Genes belonging to
cluster A were more strongly expressed in the irreversible
model, and overexpression of osteopontin and thymosin b10
persisted in the irreversible anti-Thy-1 nephritis model and
in the UUO model. The overexpression of osteopontin, a
potent macrophage chemoattractant, and of thymosin b10
suggests that macrophage infiltration and activation play a
Table 3 | Genes whose expression in the kidney differed between the reversible model and the irreversible model of anti-Thy-1
nephritis at day 42
Gene accession Name log 2 ratio
Irreversible model4reversible model
AF091577 Olfactory receptor gene Olr1370 2.0270.18
NM_012881 Osteopontin 1.9870.23
AF198087 Adrenal secretory serine protease precursor 1.9370.04
NM_012868 Natriuretic peptide receptor 3 1.8070.13
AF016178 Putative pheromone receptor (Go-VN1) 1.6170.05
X89698 Olfactory receptor gene Olr737 1.4170.59
AF035963 Kidney injury molecule 1 1.3470.21
U56822 Killer cell lectin-like receptor subfamily A, member 22 1.2570.26
U87224 Contactin associated protein 1 0.9570.31
U48828 Retroviral-like ovarian specific transcript 30-1 0.9370.48
NM_017217 Solute carrier family 7, member 3 0.8470.22
M16758 Small cytoplasmic RNA (alpha-1-RNA) 0.8370.18
M58404 Thymosin, beta 10 0.8270.19
M64387 Olr1493 0.7970.27
NM_012862 Matrix Gla protein 0.7570.43
M11842 Ornithine aminotransferase 0.7370.33
NM_012679 Testosterone-repressed prostate message 2 0.7170.04
M35601 Fibrinogen, alpha polypeptide 0.6970.26
X94551 Laminin, gamma 1 0.6770.37
NM_017184 Troponin I, skeletal, slow 1 0.6670.29
NM_013043 Transforming growth factor beta stimulated clone 22 0.6570.22
AF097887 Ras homolog gene family, member V 0.6070.35
D86742 Cadherin 4 0.6070.24
M34043 Thymosin, beta 4 0.5870.26
AF010437 MARRLC2A 0.5870.34
Irreversible modeloreversible model
M33936 Cytochrome P450, family 4, subfamily a, polypeptide 14 1.2170.11
NM_017260 Arachidonate 5-lipoxygenase activating protein 1.0170.17
M32510 Hemoglobin alpha, adult chain 1 0.8870.28
NM_012588 Insulin-like growth factor binding protein 3 0.8670.12
M32509 Hemoglobin beta chain complex 0.7570.11
U29881 Solute carrier family 5 (sodium/glucose cotransporter), member 2 0.7170.06
M11563 Nerve growth factor, gamma 0.6870.33
NM_017235 Hydroxysteroid (17-beta) dehydrogenase 7 0.6670.27
NM_012677 Tonin 0.6270.25
AJ238392 Similar to sulfotransferase K1 0.6170.23
X63854 Ransporter 2, ATP-binding cassette, sub-family B 0.6070.19
AF168362 Hspb associated protein 1 0.5870.33
NM_017013 Glutathione transferase YA subunit 0.5770.17
J00719 Cytochrome P450, 2b19 0.5770.19
The values shown are means of the log2 ratios of (irreversible model/reversible model) samples7s.d. Thus, a positive value indicates differential expression in the irreversible
model, and a negative value indicates differential expression in the reversible model.
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crucial role in progression of the renal diseases. The
mechanism of overexpression of osteopontin and thymosin
b10 in the irreversible model remains to be elucidated.
Further investigation of thymosin b10 may illuminate the
nature of progression of renal diseases.
MATERIALS AND METHODS
Animal models
Female Wistar rats, 6 weeks old, were used. The irreversible model of
anti-Thy-1 nephritis was induced as previously described.27,28
Briefly, rats were unilaterally nephrectomized and 1 week later
intravenously injected with 0.5 mg of mAb 1-22-3. The reversible
model of anti-Thy-1 nephritis was induced by injecting sham-
operated rats with the same dose of antibody. Rats were killed on
days 4, 7, 14, 42, and 56 after the injection (at least four rats each
time). As a control, four rats were unilaterally nephrectomized, not
injected with antibody, and were killed on day 56.
The UUO model was produced by ligating the left ureter at two
sites and transecting it between the ligations.9 Rats were killed on
days 1, 3, 7, 14, and 21 after surgery, and the contralateral kidneys
were used as intraindividual controls.
Rats were killed under anesthesia, and cross-sections of kidneys
were fixed in 10% neutral buffered formalin for paraffin sections
and in 4% paraformaldehyde for cryosections, and the remaining
portions of the kidney were snap-frozen in liquid nitrogen for RNA
isolation. Sections for histologic examination were stained with
periodic acid–Schiff reagent.
Urinary protein excretion was measured by the Pyrogallol Red
method before the antibody injection, and 4, 7, 14, 21, 24, 42, 49,
and 56 days after the antibody injection. The rats were given free
access to water in individual metabolic cages for collection of 24-h
urine specimens. All procedures used in the animal experiments
complied with the standards described in the Guidelines for the Care
and Use of Laboratory Animals of Keio University School of
Medicine.
Table 4 | Genes whose expression in the kidney differed between the reversible model and the irreversible model of anti-Thy-1
nephritis at day 56
Gene accession Name log 2 ratio
Irreversible model4reversible model
U06274 UDP glycosyltransferase 2 family, polypeptide B4 1.1270.46
AF091577 Olfactory receptor gene Olr1370 1.0570.19
NM_012881 Osteopontin 1.0370.07
AF198087 Adrenal secretory serine protease precursor 0.9770.22
AF035963 Kidney injury molecule 1 0.9570.36
NM_012868 Natriuretic peptide receptor 3 0.9570.27
AF016178 Putative pheromone receptor (Go-VN1) 0.9270.21
X89698 Olfactory receptor gene Olr737 0.8770.15
NM_012862 Matrix Gla protein 0.7770.13
U56822 Killer cell lectin-like receptor subfamily A, member 22 0.7770.36
M58404 Thymosin, beta 10 0.7670.22
M64387 Olr1493 0.7570.20
J00705 Apolipoprotein E 0.7570.35
M12199 Collagen, type I, alpha 1 0.7370.28
M35601 Fibrinogen, alpha polypeptide 0.6870.21
NM_013043 Transforming growth factor beta stimulated clone 22 0.6670.13
U69487 ATP-binding cassette, sub-family B (MDR/TAP), member 11 0.6670.29
NM_017184 Troponin I, skeletal, slow 1 0.6570.28
U42719 Complement component 4, gene 2 0.6470.38
NM_012679 Testosterone-repressed prostate message 2 0.6470.34
NM_013098 Glucose-6-phosphatase, catalytic 0.6070.18
Irreversible modeloreversible model
S62516 SA rat hypertension-associated homolog 1.3870.39
U48828 Retroviral-like ovarian specific transcript 30-1 0.9270.40
AF053988 Tissue-type vomeronasal neurons putative pheromone receptor V2R1-1 0.9170.52
D10693 Histamine N-methyltransferase 0.7570.33
M55250 Glycine receptor, alpha 3 subunit 0.7470.35
NM_012909 Aquaporin 2 0.7470.25
S81497 Lipase A, lysosomal acid 0.6970.34
NM_012817 Insulin-like growth factor binding protein 5 0.6970.41
AF205717 Transmembrane 4 superfamily member 4 0.6870.37
AF060173 SV2 related protein 0.6770.26
U24070 Unc-13 homolog A 0.6270.35
NM_019282 Gremlin 1 homolog, cysteine knot superfamily 0.6170.23
AJ295749 Xylosyltransferase II 0.6070.28
M92042 N-deacetylase/N-sulfotransferase (heparan glucosaminyl) 1 0.6070.34
NM_017136 Squalene epoxidase 0.5970.27
AF264005 Fucosyltransferase 2 (secretor status included) 0.5970.22
The values shown are means of the log 2 ratios of (irreversible model/reversible model) samples7s.d. Thus, a positive value indicates differential expression in the irreversible
model, and a negative value indicates differential expression in the reversible model.
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Microarray experiments
cDNA probes were synthesized from 2.0 mg of poly(A)þ RNA by a
two-step procedure using the CyScribe Post-Labeling Kit (Amer-
sham Biosciences Corp., Piscataway, NJ, USA). In the first step,
amino allyl-dUTP was incorporated into first-strand cDNA during
reverse transcription. In the second step, the amino allyl-modified
cDNA was chemically labeled with CyDyeTM NHS-esters (either Cy3
or Cy5 signal). The Cy3- or Cy5-labeled cDNA probes were then
combined and diluted in 30 ml of ArrayHybTM Low Temp
Hybridization Buffer (Sigma, St Louis, MO, USA).
Oligonucleotide microarrays with approximately 4854 rat genes
(DNA chip consortium, Sigma Genosys Japan, Hokkaido, Japan)
were used. Microarray slides were prehybridized in 5 SSC, 0.1%
SDS, and 1% BSA at 421C for 1 h. Labeled cDNA probes were
hybridized with the microarray slides by overnight incubation at
421C. The slides were washed with 1 SSC and 0.03% SDS at 421C
for 4 min, then with 0.2 SSC at room temperature for 4 min, and
finally with 0.05 SSC at room temperature for 4 min. Hybridiza-
tion images were scanned with a GenePix 4000A scanner (Axon
Instrument Inc., Foster City, CA, USA), and the fluorescence
intensity of Cy3 and Cy5 was quantitated with GenePix Pro 3.0
software (Axon Instrument Inc.). To avoid the effect of putative
artificial signals caused by nonspecific dye–cDNA interactions, each
hybridization was performed twice, where the second experiment was
performed with a reversed Cy-dye assignment (the so-called ‘dye
flip’). At least four hybridizations were performed at each time point.
The ratio of the Cy3 to Cy5 signal intensity (Cy3/Cy5) was log2-
transformed, and each log2(Cy3/Cy5) value was normalized by
subtracting the average of the log2(Cy3/Cy5) values for the
glyceraldehyde 3-phosphate dehydrogenase genes. Genes with
median log2 values for the ratios X1 or p1 were considered
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Figure 4 | Real-time PCR for the selected genes in the kidney in
the reversible and irreversible models of anti-Thy-1 nephritis.
mRNA was prepared from the kidneys of the irreversible and
reversible model rats at times indicated and subjected to real-time
(a) PCR for KIM-1, (b) osteopontin, and (c) thymosin b10. The black
and white bars at each time point represent expression in the
irreversible and the reversible nephritis kidney, respectively. Data
were normalized for the amount of 18S ribosomal RNA in each
sample and are expressed relative to the value measured in the
control sample. Mean values7s.e.m. are shown. *Po0.05 compared
to the reversible model at the same time point.
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Figure 5 | Real-time PCR for the selected genes in the unilateral
ureteral obstruction model. mRNA was prepared from unob-
structed right kidneys (R, white bar) and obstructed left kidney (L,
black bar) at the times indicated, and subjected to real-time PCR for
(a) KIM-1, (b) osteopontin, and (c) thymosin b10. Data were
normalized for the amount of 18S ribosomal RNA in each sample and
expressed relative to the value measured in the kidney on the side at
day 1. Mean values7s.e.m. are shown. *Po0.05 compared to the
value in the contralateral kidneys.
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Figure 6 | Imunohistochemical localization of thymosin b10.
Expression of thymosin b10 was immunolocalized in the kidney in the
(a) irreversible anti-Thy-1 nephritis model at day 14, (b) in the
reversible anti-Thy-1 nephritis model at day 14, and (c) in the uni-
lateral ureteral obstruction model at day 7. Brown represents
immunopositivity; nuclei are stained blue. (d–f) Double immunostain-
ing of the kidney in the irreversible anti-Thy-1 nephritis model at day
14 with anti-thymosin b10 antibody and the macrophage marker ED-1.
Nuclei were visualized by blue 4,6-diamidino-2-phenylindole staining.
(d) Immunoreactivity for thymosin b10 was visualized with red.
(e) Immunoreactivity for ED-1 was visualized with green.
(f) Merged image. (Original magnification 400).
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upregulated (two-fold or more) or downregulated (two-fold or
more), respectively. Average-linkage hierarchical clustering analysis
was applied to the 189 differentially expressed genes with clustering
software Cluster 3.0 (http://bonsai.ims.u-tokyo.ac.jp/~mdehoon/
software/cluster/) and visualized by Java TreeView 1.0.4 (http://
genetics.stanford.edu/~alok/TreeView/).
Semiquantitative RT-PCR and real-time PCR
For semiquantitative analysis, the number of amplification cycle of
PCR was determined in the exponential phase. Glyceraldehyde
dehydrogenase mRNA levels were used to standardize the mRNA
levels of the target genes.
Real-time PCR was performed as described previously.29 The
PCR primers and TaqMan probes were designed using Primer
Express software 1.5 (Applied Biosystems, Foster City, CA, USA).
The RNA sample (50 mg) was exposed to DNase to remove the DNA,
and then amplified with TaqMan Gold PCR Reagents (Applied
Biosystems). The PCR reactions were monitored in real time with
the ABI PRISM 7700 Sequence Detector (Applied Biosystems). All
data were normalized by using 18S ribosomal RNA as an
endogenous control.
Immunohistochemical study
Paraffin sections were deparaffinized and hydrated, and antigen was
retrieved by boiling the tissue for 10 min in 10 mM citric acid, pH
6.0. After washes, the slides were hybridized with anti-thymosin b10
antibody (Biodesign International, Saco, ME, USA) at 41C over-
night. The anti-thymosin b10 antibody was raised against the
human thymosin b10 peptide (aa 1–12) and does not crossreact with
other subtypes of b-thymosin. Antigen-bound primary antibody
was detected with the DAKO LSAB2 Kit (Dako, Carpinteria, CA,
USA). The chromogen substrate was diaminobenzidine, and the
sections were counterstained with hematoxylin.
For double immunostaining, cryosections were incubated with anti-
thymosin b10 antibody and monoclonal antibody ED-1 (Chemicon
International Inc., Temucula, CA, USA). Alexa Fluor 594-conjugated
anti-rabbit IgG and Alexa Fluor 488-conjugated anti-mouse IgG
(Invitrogen Corp., Carlsbad, CA, USA) were used as secondary
antibodies. The nuclei were stained with 4,6-diamidino-2-phenylindole.
Statistical analysis
Statistical significance was evaluated by Student’s t-test or one-way
analysis of variance with a Fisher’s post hoc test, as appropriate.
Statistical significance was defined as Po0.05. All values are
expressed as means7s.e.m.
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